Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants
Juan Liu, Fengfeng Mao, Jianhe Chen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10

Showing 10 citing articles:

Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness
Wenhao Liu, Zehong Huang, Jin Xiao, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 184-184
Open Access | Times Cited: 24
Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy
Yufei Xiang, Jialu Xu, Briana L. McGovern, et al.
Cell (2024)
Closed Access | Times Cited: 7
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies
Hailong Guo, Sha Ha, Jason Botten, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 697-697
Open Access | Times Cited: 6
Therapeutic antibodies and alternative formats against SARS-CoV-2
Rahel R. Winiger, Laurent Perez
Antiviral Research (2024) Vol. 223, pp. 105820-105820
Open Access | Times Cited: 4
Engineering a “muco‐trapping” ACE2‐immunoglobulin hybrid with picomolar affinity as an inhaled, pan‐variant immunotherapy for COVID‐19
Karthik Tiruthani, Carlos Cruz‐Teran, Jasper Fuk‐Woo Chan, et al.
Bioengineering & Translational Medicine (2024) Vol. 9, Iss. 4
Open Access | Times Cited: 3
An ACE2-Fc decoy produced in glycoengineered plants neutralizes ancestral and newly emerging SARS-CoV-2 variants and demonstrates therapeutic efficacy in hamsters
Esther Föderl-Höbenreich, Shiva Izadi, Lara Hofacker, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Nasal spray of an IgM‐like ACE2 fusion protein HH‐120 accelerates SARS‐CoV‐2 clearance: A single‐center propensity score‐matched cohort study
Rui Song, Xiaoyou Chen, Baoliang Li, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 5
Closed Access | Times Cited: 7
Broadly Effective ACE2 Decoy Proteins Protect Mice from Lethal SARS-CoV-2 Infection
Mengjia Lu, Weitong Yao, Yujun Li, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 5
Clinical development of antivirals against SARS-CoV-2 and its variants
Qiaoshuai Lan, Yan Yan, Guangxu Zhang, et al.
Current Research in Microbial Sciences (2023) Vol. 6, pp. 100208-100208
Open Access | Times Cited: 2
Nasal spray of an IgM‐like ACE2 fusion protein HH‐120 prevents SARS‐CoV‐2 infection: Two investigator‐initiated postexposure prophylaxis trials
Rui Song, Xiaoyou Chen, Baoliang Li, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 12
Open Access | Times Cited: 1
Page 1

Scroll to top